ZEST trial fails to meet enrollment goals for ctDNA testing in breast cancer
The ZEST clinical trial, designed to evaluate niraparib (Zejula) for the prevention of breast cancer recurrence in patients with circulating
Read moreThe ZEST clinical trial, designed to evaluate niraparib (Zejula) for the prevention of breast cancer recurrence in patients with circulating
Read moreAnalyses of self-tests for human papillomavirus (HPV) can be used to divide HPV-positive women into three risk groups, according to
Read moreDILI is broadly categorized into intrinsic and idiosyncratic types. Intrinsic hepatotoxins, such as APAP, cause dose-dependent injury, while idiosyncratic DILI
Read moreResearchers examine the evolution of hepatitis E virus, which infects 20 million people annually and causes 44,000 deaths worldwide Study: Ancient
Read moreImlunestrant, an investigational next-generation selective estrogen receptor degrader (SERD), improved progression-free survival in patients with endocrine therapy-pretreated, ER-positive, HER2-negative advanced
Read moreABB has launched ChloroStar, a family of sensors, transmitters and accessories for accurate and reliable chlorine measurement and analysis that
Read moreIn large engineering plants, it can be difficult to identify when a circuit breaker has been tripped, especially when navigating
Read morePublished: 11 December, 2024 The UK’s underwater industry has grown from £8bn to £9.2bn in the last 12 months and
Read morePublished: 11 December, 2024 Ocean Winds has announced it has appointed Føn Energy Services to provide a fully integrated Balance
Read moreAdvances in medicine have led to an increase in human longevity. Estimates suggest that by 2030, one in every six
Read more